Label-Free Detection Market Worth $626 Million By 2025 - Exclusive Report By MarketsandMarkets™
Seeking Alpha Analyst Since 2014
#Healthcare Consultant focusing on #TeleHealth #TeleMedicine #PatientPortals #CVIS #HCIT #MedicalRobots #Vaccines #MedicalDevices #WirelessHealth #Biotechnology
- The global Label-Free Detection Market size is estimated to be USD 431 million in 2020 and projected to reach USD 626 million by 2025, at a CAGR of 7.7%.
According to the new market research report "Label-free Detection Market by Product & Service (Instruments, Consumables (Biosensor Chip), Software), Technology (Surface Plasmon Resonance), Application (Binding Kinetics), End User (Pharmaceutical & Biotechnology Companies) & region - Global Forecast to 2025", published by MarketsandMarkets™,the global Label-Free Detection Market size is estimated to be USD 431 million in 2020 and projected to reach USD 626 million by 2025, at a CAGR of 7.7%.
Browse in-depth TOC on "Label-free Detection Market"
187 – Tables29 – Figures 193 – Pages
Download PDF Brochure:- Label-free Detection Market
The Growth in this market is largely driven by the introduction of technologically advanced products, a growing number of drug discovery programs through academic-industrial partnerships, and the high sensitivity of label-free technologies.
The instruments segment accounted for the largest share of the product & service segment in the label-free detection market in 2019.
On the basis of product & service, the market is broadly segmented into instruments, consumables and software & services. The consumables segment is further segmented into biosensor chips, microplates and reagents & kits. In 2019, instruments accounted for the largest share of the label-free detection products market owing to the various technological advancements in label-free detection systems.
The surface plasmon resonance segment accounted for the largest share of the technology segment in the market in 2019.
On the basis of technology, the market is categorized into five technology segments—surface plasmon resonance, bio-layer interferometry, differential scanning calorimetry, isothermal titration calorimetry, and other label-free detection technologies. The surface plasmon resonance segment accounted for the largest share in 2019, due to the high sensitivity of this technology and its wide usage in determining specificity, affinity, and kinetic parameters during the binding of macromolecules.
The Asia Pacific region is the fastest growing region of the label-free detection market in 2019.
In 2019, Asia Pacific region accounted for the fastest growing region of the market. It is also estimated to grow at the highest CAGR in the market during the forecast period, this is mainly due to the rising awareness, increasing government support and funding, and growth in life science research.
Get 10% Customization on this Research Report:- Label-free Detection Market
Some of the leading players in the label-free detection market include Danaher (US), Sartorius AG (Germany), Waters Corporation (US), PerkinElmer Inc. (US), AMETEK, Inc. (US), HORIBA Ltd. (Japan), Spectris (UK), METTLER TOLEDO (US), Corning Incorporated (US), and Agilent Technologies, Inc. (US)
Browse Related Reports:Cell Analysis Market by Product [Microscope, Spectrophotometers, Flow cytometry (Software, Accessories)], Process (Cell Viability, Cell Proliferation, Signal Transduction), End User (Pharma, Research, Biotechnology Companies) - Global Forecast to 2024 Cell Analysis MarketHigh-Throughput Screening (HTS) Market by Product (Instruments, Software, Service), Technology (Cell-Based Assays, Label-Free), Application (Drug Discovery, Biochemical Screening, Research), End User (Pharma & Biotech, CROs)- Global Forecast to 2025 High-Throughput Screening Market - Global Forecast to 2025 | MarketsandMarkets
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.